Clinical Trial Update: Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial) [Phase 1]

View source ↗

Summary

This Clinical Trial Update describes BaseCAR-01, a Phase 1 study evaluating bispecific CAR T cells in B-cell malignancies, with recruitment not yet underway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Leukemia
• B-cell Lymphoma
• B-cell Malignancies

Drugs mentioned

• BaseCAR-01 bispecific CAR T cells

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: B Cell Malignancies, B-cell Leukemia | Phase 1 | Status: NOT_YET_RECRUITING